Related Experiment Video

Updated: Jun 1, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Oncolytic virotherapy for pancreatic cancer

Sonia Wennier1, Shoudong Li, Grant McFadden

  • 1Molecular Genetics and Microbiology Department, University of Florida, Gainesville, FL 32610, USA.

Expert Reviews in Molecular Medicine
|June 17, 2011
PubMed

Insights

Oncolytic viruses (OVs) show promise for treating pancreatic cancer. This review explores various OVs, their unique biology, and potential for genetic modification or combination therapies to enhance efficacy.

Area of Science:

  • Virology
  • Oncology
  • Cancer Therapeutics

Background:

  • Pancreatic cancer research has identified key biological factors and pathways.
  • Oncolytic viruses (OVs) are being investigated as novel treatments for pancreatic cancer.
  • Several types of OVs, including adenoviruses, herpesviruses, reoviruses, poxviruses, and parvoviruses, are under study.

Purpose of the Study:

  • To review replication-competent oncolytic viruses (OVs) investigated for pancreatic cancer therapy.
  • To highlight the unique viral biology that supports their potential as virotherapies.
  • To discuss strategies for improving OV efficacy through genetic manipulation and combination therapies.

Main Methods:

  • Literature review of studies on oncolytic viruses and pancreatic cancer.
  • Analysis of pancreatic cancer biology to understand therapeutic targets and pathways.
  • Synthesis of information on viral characteristics and potential treatment enhancements.

Main Results:

  • Various oncolytic viruses (OVs) are being explored for pancreatic cancer treatment, with some in clinical trials.
  • Understanding pancreatic cancer biology informs the selection and development of effective OVs.
  • Genetic engineering and combination strategies offer avenues to boost OV therapeutic potential.

Conclusions:

  • Replication-competent oncolytic viruses (OVs) represent a promising therapeutic avenue for pancreatic cancer.
  • Tailoring OVs based on pancreatic cancer's molecular biology is crucial for efficacy.
  • Further research into viral manipulation and combination treatments can optimize oncolytic virotherapy for pancreatic cancer.

More Related Videos

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...